CABM

CABM Home
About CABM
Faculty & Research
Education & Seminars
Symposium
Employment
Directory

Site Tools
Search
Contact
Site Map


  Faculty & ResearchFaculty & Research

<Faculty List

 

Eileen White

Professor
Department of Molecular Biology and Biochemistry
Rutgers, The State University of New Jersey

Associate Director for Basic Science
Cancer Institute of New Jersey


Adjunct Professor
Department of Surgery, UMDNJ-RWJMS


Ph.D., 1983, SUNY, Stony Book, NY

Tel:  [732] 235-5329
Fax: [732] 235-5795
ewhite@cabm.rutgers.edu
http://white.cabm.rutgers.edu/

Adenovirus, p53, apoptosis, oncogenes, programmed cell death, tumor suppressor genes, cancer, E1B, Bcl-2, cell cycle, caspase.

Regulation of Apoptosis by Viral Oncogenes

Primary epithelial cells become transformed as a result of the combined action of deregulation of cell cycle control and inhibition of programmed cell death (apoptosis). Expression of the human adenovirus (Ad2/5) E1A oncogene releases normal restrictions on cell cycle progression through interactions with the retinoblastoma tumor suppressor protein and its relatives, and with the p300 and CBP transcriptional co-activators. The cellular response to this deregulation of cell growth control by E1A is the stabilization of the p53 tumor suppressor protein and the induction of p53-dependent apoptosis. The activation of this apoptotic program prevents transformation and can diminish virus replication. The adenonvirus E1B oncogene encodes two proteins (E1B 19K and 55K) that function to inhibit apoptosis, which thereby sustains transformation and productive infection. E1B 55K functions by interacting with and inhibiting p53, whereas E1B 19K is a viral Bcl-2 homologue which functions as a general apoptosis inhibitor by binding to and inhibiting components of the apoptotic machinery. The long-term focus of the White laboratory has been to determine the mechanism by which E1A induces, and E1B 19K inhibits, apoptosis. As deregulation of apoptosis is a common feature of many disease states, knowledge gained by this pursuit should provide new opportunities for the development of novel therapies, particularly for cancer treatment. More information can be obtained from the White Laboratory Website.

Selected Publications1

    Jin S, DiPaola RS, Mathew R, White E.  (2007) Metabolic catastrophe as a means to cancer cell death.  J. Cell Sci. 120:379-83

    Jin, S. and White, E.  (2007) Role of autophagy in cancer: management of metabolic stress.  Autophagy 3:28-31

    Degenhardt K, White E.   (2006) A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis.  Clin Cancer Res. 12:5298-304

    Mathew R, White E.   (2006) FLIPping the balance between apoptosis and proliferation in thyroid cancer.  Clin Cancer Res. 12:3648-51

    White E.   (2006)  Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis.  Cell Death Diff. 13:1371-7

    Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, Nelson DA, Jin S, White E.   (2006)  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis.  Cancer Cell 10:51-64

CABM Home Top